Combination chemo-immunotherapy (BOLD plus interferon-alpha) for matastatic melanoma, a multicenter phase II study
SourceBritish Journal of Cancer, 76, (1997), pp. 266-269
Article / Letter to editor
Display more detailsDisplay less details
British Journal of Cancer
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.